Use of a human tumor cloning system to screen retinoids for antineoplastic activity

Cancer. 1983 Jan 1;51(1):92-6. doi: 10.1002/1097-0142(19830101)51:1<92::aid-cncr2820510119>3.0.co;2-r.

Abstract

Retinoid analogs are being actively evaluated as antitumor agents in man. A human tumor cloning system was used to assess the antineoplastic activity of all-trans-retinoic acid, all-trans-retinol and 13-cis-retinoic acid. The effect of retinoids on the formation of tumor colony forming units (T-CFU) was surveyed for 67 different human tumors. These analogs showed minor activity in a variety of neoplasms. The decrease in T-CFU varied between histologic tumor types and between tumor of the same type. No significant difference between retinoid analogs was noted.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Division / drug effects
  • Cells, Cultured
  • Drug Evaluation, Preclinical / methods*
  • Humans
  • In Vitro Techniques
  • Isomerism
  • Isotretinoin
  • Retinaldehyde / analogs & derivatives*
  • Time Factors
  • Tretinoin / pharmacology
  • Vitamin A / analogs & derivatives*
  • Vitamin A / pharmacology

Substances

  • Antineoplastic Agents
  • Vitamin A
  • Tretinoin
  • Isotretinoin
  • Retinaldehyde